Compare CGEM & SSTK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CGEM | SSTK |
|---|---|---|
| Founded | 2016 | 2003 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 671.7M | 675.2M |
| IPO Year | 2021 | 2012 |
| Metric | CGEM | SSTK |
|---|---|---|
| Price | $12.37 | $18.09 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 8 | 2 |
| Target Price | ★ $28.00 | $25.00 |
| AVG Volume (30 Days) | ★ 1.3M | 179.3K |
| Earning Date | 11-06-2025 | 11-05-2025 |
| Dividend Yield | N/A | ★ 7.30% |
| EPS Growth | N/A | ★ 66.87 |
| EPS | N/A | ★ 1.69 |
| Revenue | N/A | ★ $1,020,010,000.00 |
| Revenue This Year | N/A | $11.41 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $10.73 |
| Revenue Growth | N/A | ★ 13.06 |
| 52 Week Low | $5.68 | $14.35 |
| 52 Week High | $13.60 | $38.80 |
| Indicator | CGEM | SSTK |
|---|---|---|
| Relative Strength Index (RSI) | 67.30 | 31.14 |
| Support Level | $10.01 | $19.72 |
| Resistance Level | $13.33 | $21.68 |
| Average True Range (ATR) | 1.21 | 0.78 |
| MACD | 0.12 | -0.16 |
| Stochastic Oscillator | 81.18 | 2.37 |
Cullinan Therapeutics Inc is a biopharmaceutical company. It has a diversified portfolio of clinical-stage assets that inhibit key drivers of disease or harness the immune system to eliminate diseased cells in both oncology and autoimmune diseases. Its understanding of oncology, immunology, and translational medicine, creates differentiated ideas, identifies the appropriate targets, and selects the optimal modality to develop transformative therapeutics across a variety of cancer and autoimmune indications. It has one reporting and one operating segment, which is the business of developing immunology and oncology therapies.
Shutterstock Inc is a U.S.-based company that is engaged in the provision of digital content. The content segment, whose offerings include licenses for Images, Footage, Music, 3 Dimensional, and Generative AI content. Data, Distribution, and Service offerings address customer demand for products and services that are beyond its Content licenses. The company generates the majority of its revenue from Content offerings. Geographically the company generates the majority of its revenue from the Domestic market, but also has its presence in Europe and Rest of the Countries.